AG

Ankit Gupta

Active Director Director DIN 10938738
DIN 10938738 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankit Gupta

Data last updated:

Ankit Gupta is a Director at Neofem Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10938738
Primary Designation Director
Industry Pharma
First Appointment 10 Feb 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20252024Active

Directorship timeline

Open interactive timeline →
Neofem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ankit Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankit Gupta

Ankit Gupta currently holds 1 directorship: Neofem Pharmaceuticals Private Limited (Director, since 10 Feb 2025).

Ankit Gupta was first appointed on 10 Feb 2025 as Director at Neofem Pharmaceuticals Private Limited.

The current boards of Ankit Gupta's companies include Abhimanyu Mahajan (Neofem Pharmaceuticals Private Limited), Jitendra Kumar Dashore (Neofem Pharmaceuticals Private Limited), Kapil Mahajan (Neofem Pharmaceuticals Private Limited), Kunal Mandloi (Neofem Pharmaceuticals Private Limited), Priyank Kumar Moyade (Neofem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available